Geron reported $60.19M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Amgen USD 10.4B 300M Sep/2026
Bio Techne USD 299.71M 21.49M Sep/2026
Cytokinetics USD 47.6M 19M Sep/2026
Exelixis USD 658.69M 30M Sep/2026
Genmab DKK 1.16B 259M Jun/2026
Geron USD 60.19M 2.71M Sep/2026
Gilead Sciences USD 8.3B 500M Sep/2026
Incyte USD 1.56B 110M Sep/2026
MacroGenics USD 32.83M 12.03M Jun/2026
Novartis USD 14.52B 112M Sep/2026
Novavax USD 147.14M 76.69M Dec/2025